N-linked glycosylation of the human bradykinin B2 receptor is required foroptimal cell-surface expression and coupling
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378916181 | ||
| 003 | CHVBK | ||
| 005 | 20180305123553.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20040105xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/BC.2004.007 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/BC.2004.007 | ||
| 245 | 0 | 0 | |a N-linked glycosylation of the human bradykinin B2 receptor is required foroptimal cell-surface expression and coupling |h [Elektronische Daten] |c [S. Michineau, L. Muller, A. Pizard, F. Alhenc-Gélas, R. M. Rajerison] |
| 520 | 3 | |a To investigate the glycosylation of the human bradykinin B2 receptor and the functional significance of this modification, we studied receptors mutated at single or multiple combinations of the three potential N-linked glycosylation sites, asparagines N3, N12 and N180, in COS-7, HEK 293 and CHOK1 cells. Western blot experiments demonstrated that all three extracellular asparagines are glycosylated. The kinetics of bradykinin binding and receptor sequestration remained unchanged after glycosylation had been suppressed. However, the glycosylated receptors were expressed at the cellsurface to a much greater extent than the nonglycosylated receptor and coupling to phospholipase C was less efficient for receptor lacking N-terminal glycosylation. These results indicate that, for the human bradykinin B2 receptor, glycosylation is not required for optimal ligand binding, but plays an important role in cell-surface addressing and receptor function. | |
| 540 | |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Biochemistry |2 nationallicence | |
| 690 | 7 | |a Molecular biology |2 nationallicence | |
| 690 | 7 | |a Cellular biology |2 nationallicence | |
| 700 | 1 | |a Michineau |D S. |4 aut | |
| 700 | 1 | |a Muller |D L. |4 aut | |
| 700 | 1 | |a Pizard |D A. |4 aut | |
| 700 | 1 | |a Alhenc-Gélas |D F. |4 aut | |
| 700 | 1 | |a Rajerison |D R. M. |4 aut | |
| 773 | 0 | |t Biological Chemistry |d Walter de Gruyter |g 385/1(2004-01-05), 49-57 |x 1431-6730 |q 385:1<49 |1 2004 |2 385 |o bchm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/BC.2004.007 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/BC.2004.007 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Michineau |D S. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Muller |D L. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Pizard |D A. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Alhenc-Gélas |D F. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Rajerison |D R. M. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Biological Chemistry |d Walter de Gruyter |g 385/1(2004-01-05), 49-57 |x 1431-6730 |q 385:1<49 |1 2004 |2 385 |o bchm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||